AnalystsLaura Prendergast
Laura Prendergast's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 10%
#527 out of 5326 analysts
Average Return
+88.3%
Win Rate
59%13 out of 22
Risk vs Reward
Poor
Good

Laura Prendergast's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Erasca IncERAS
+980.41%$1.48$15.99
2025-03-26 -
2026-03-25
Buy
Erasca IncERAS
+657.71%$2.53$19.17
2025-10-16 -
2026-07-17
Strong Buy
Revolution Medicines IncRVMD
+274.72%$49.68$186.16
2025-10-16 -
2026-07-17
Strong Buy
Tango Therapeutics IncTNGX
+188.48%$9.90$28.56
2025-12-04 -
2026-07-17
Strong Buy
Tango Therapeutics IncTNGX
+73.62%$16.45$28.56
2026-03-09 -
2026-07-17
Strong Buy

Laura Prendergast's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Tango Therapeutics IncTNGX
3Strong Buy$40.00+40.06%Maintains
3 months ago
Erasca IncERAS
3Strong Buy$30.00+56.49%Maintains
3 months ago
Revolution Medicines IncRVMD
5Strong Buy$215.00+15.49%Reiterates
3 months ago
Olema Pharmaceuticals IncOLMA
1Strong Buy$48.00+318.48%Initiates Coverage On
5 months ago
Bridgebio Oncology Therapeutics IncBBOT
1Strong Buy$23.00+168.69%Initiates Coverage On
5 months ago
Foghorn Therapeutics IncFHTX
1Strong Buy$12.00+131.21%Initiates Coverage On
8 months ago
Nuvalent IncNUVL
2Strong Buy$135.00+8.91%Maintains
8 months ago
Black Diamond Therapeutics IncBDTX
2Strong Buy$8.00+346.93%Reinstates
9 months ago
Cogent Biosciences IncCOGT
1Hold$16.00-59.06%Initiates Coverage On
9 months ago
Mural Oncology PLCMURA
1Strong Buy$18.00N/AInitiates Coverage On
2 years ago
Nkarta IncNKTX
2Strong Buy$16.00N/AUpgrades
2 years ago
Third Harmonic Bio IncTHRD
1Buy$18.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.